Related Experiment Video
Updated: Sep 10, 2025

08:55
Murine Model for Non-invasive Imaging to Detect and Monitor Ovarian Cancer Recurrence
Published on: November 2, 2014
12.4K
Ovarian relapse in a child with B-ALL: a case report
Meriem Cheikhna1, Chaimae El Mahdaoui2, Nisrine Bennani Guebessi2,3
1Hematology and Pediatric Oncology Department of August 20 Hospital, Ibn Rochd University Hospital, Casablanca, Morocco.
The Pan African Medical Journal
|August 27, 2025
Summary
An 8-year-old girl with B-cell acute lymphoblastic leukemia (B-ALL) experienced a rare ovarian relapse. This highlights the need for vigilant follow-up and imaging in pediatric ALL patients post-remission.
Area of Science:
- Pediatric Oncology
- Hematology
- Genetics
Background:
- B-cell acute lymphoblastic leukemia (B-ALL) is a common childhood cancer.
- Favorable genetic markers, like chromosome 12 deletion associated with ETV6-RUNX1, can still carry a risk of late relapse.
- Extramedullary relapses, particularly in the ovary, are exceptionally rare in pediatric B-ALL.
Observation:
- An 8-year-old girl with B-ALL and chromosome 12 deletion presented with an asymptomatic ovarian relapse after achieving remission.
- Pelvic pain was the initial clinical symptom, leading to diagnosis via pelvic ultrasound.
- The ovarian relapse showed a partial response to standard B-ALL chemotherapy.
Findings:
- This case documents an extremely rare instance of ovarian extramedullary relapse in pediatric B-ALL.
- The patient's chromosome 12 deletion, typically favorable, was associated with a late relapse.
- Early detection of extramedullary relapse was delayed due to asymptomatic presentation.
Implications:
- Highlights the importance of considering extramedullary relapse in pediatric ALL patients with atypical symptoms post-remission.
- Suggests routine pelvic ultrasound may aid early detection of ovarian and other extramedullary relapses.
- Emphasizes the need for vigilant, targeted surveillance in ALL survivors, even those with initially favorable genetic profiles, to identify late relapses.
Related Concept Videos
Treatment Resistant Cancers
3.4K
Cancer is the second leading cause of death in the United States. A cancer cell is genetically unstable and hence can mutate faster. They can also modify their microenvironment and escape immune surveillance. The difficulties in treating cancer are further compounded by the emergence of rapid resistance to anticancer drugs. The most common ways to attain resistance in cancer cells include alteration in drug transport and metabolism, modification of drug target, elevated DNA damage response, or...
3.4K
Bone Marrow Sampling and Transplants
495
Bone marrow transplant is a potential cure for several diseases, including cancer and specific genetic disorders. Notably, this procedure is applicable for patients suffering from aplastic anemia, certain types of leukemia, severe combined immunodeficiency disease (SCID), Hodgkin's disease, non-Hodgkin's lymphoma, multiple myeloma, thalassemia, sickle-cell disease, and certain cancers.
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
The transplant begins with high doses of chemotherapy and radiation treatment, which aim to destroy...
495

